[Successful rituximab treatment of TAFRO syndrome refractory to glucocorticoids and tocilizumab].

MLA

Sumi, Chihiro, et al. “[Successful Rituximab Treatment of TAFRO Syndrome Refractory to Glucocorticoids and Tocilizumab].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, vol. 64, no. 4, 2023, pp. 265–70. EBSCOhost, https://doi.org/10.11406/rinketsu.64.265.

APA

Sumi, C., Toki, Y., Funayama, T., Saito, T., Hatayama, M., Yamamoto, M., Shindo, M., Yuzawa, S., Tanino, M., & Okumura, T. (2023). [Successful rituximab treatment of TAFRO syndrome refractory to glucocorticoids and tocilizumab]. [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 64(4), 265–270. https://doi.org/10.11406/rinketsu.64.265

Chicago

Sumi, Chihiro, Yasumichi Toki, Takuya Funayama, Takeshi Saito, Mayumi Hatayama, Masayo Yamamoto, Motohiro Shindo, Sayaka Yuzawa, Mishie Tanino, and Toshikatsu Okumura. 2023. “[Successful Rituximab Treatment of TAFRO Syndrome Refractory to Glucocorticoids and Tocilizumab].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology 64 (4): 265–70. doi:10.11406/rinketsu.64.265.